2026

Queen Mary researchers lead report on avoidable inequalities in cardiovascular disease burden and care
22 May 2026

Researchers from the William Harvey Research Institute at Queen Mary University of London have led a major new report revealing the continuing and unequal burden of cardiovascular disease (CVD) across Europe.

Drug that targets immune cells shows potential as new treatment for diabetic heart disease
27 February 2026

Researchers from Queen Mary University of London have found that a medication originally developed for glycemic control can reverse serious heart damage — not by controlling blood sugar as originally intended, but by retraining the immune system to protect the heart from within.

High-risk patients account for 80% of post-surgery deaths
25 February 2026

Large UK-wide study shows that high-risk patients account for nearly 80% of post-surgery deaths, highlighting the need for open conversations and more tailored care.